American Journal of Cardiology
Volume 103, Issue 12 , Pages 1703-1709 , 15 June 2009

Potential Reductions in United States Coronary Heart Disease Mortality by Treating More Patients

  • Simon Capewell, DSc

      Affiliations

    • Division of Public Health, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Martin O'Flaherty, MD, Msc

      Affiliations

    • Division of Public Health, University of Liverpool, Liverpool, United Kingdom
    • Corresponding Author InformationCorresponding author: Tel: +44-15-1794-5273; fax: +44-15-1794-5588
    • ,
  • Earl S. Ford, MD, MPH

      Affiliations

    • Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
    • ,
  • Julia A. Critchley, DPhil

      Affiliations

    • Institute of Health Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom

Received 30 September 2008 ,Revised 5 February 2009 ,Accepted 5 February 2009.

References 

  1. Ford EA, Ajani UA, Croft JB, Critchley Ja, Labarthe DR, Kottke TE, et al. Explaining the decline in coronary mortality in the United States between 1980 and 2000. N Engl J Med. 2007;356:2388–2398
  2. US Department of Health and Human Services, Centers for Disease Control and Prevention. A public health action plan to prevent heart disease and stroke. http://www.cdc.gov/DHDSP/library/action_plan/Accessed on July 16, 2007
  3. Unal B, Critchley J, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales, 1981–2000. Circulation. 2004;109:1101–1107
  4. NCHS-CMS Linkage: Medicare Enrollment and Claims Files (2000). http://www.cdc.gov/nchs/r&d/nchs_datalinkage/data_linkage_cms.htmAccessed November 15, 2007
  5. van Domburg R, Miltenburg-van-Zijl AJ, Veerhoek R, Simoons ML. Unstable angina: good long-term outcome after a complicated early course. J Am Coll Cardiol. 1998;31:1534–1539
  6. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ. 1995;311:793–796
  7. Nichol MB, Venturini F, Sung JC. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother. 1999;33:531–540
  8. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825–836
  9. Capewell S, Pell JP, Morrison C, McMurray J. Increasing the impact of cardiological treatments: how best to reduce deaths. Eur Heart J. 1999;20:1386–1392
  10. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516
  11. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ. 1994;3:95–104
  12. Beaglehole R. International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev. 1990;12:1–15
  13. Goldman L, Cook F. The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825–836
  14. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22:554–572
  15. Capewell S, Unal B, Critchley JA, McMurray JJ. Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients. Heart. 2006;92:521–523
  16. Kabir Z, Bennett K, Shelley E, Unal B, Critchley J, Feely J, et al. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland. QJM. 2006;99:523–530
  17. Bennett K, Kabir Z, Unal B, Shelley E, Critchley J, Perry I, et al. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985–2000. J Epidemiol Commun Health. 2006;60:322–327
  18. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:1866–1868
  19. Ayanian JZ, Quinn TJ. Quality of care for coronary heart disease in two countries. Health Aff (Millwood). 2001;20:55–67
  20. Birkhead JS, Walker L, Pearson M, Weston C, Cunningham AD, Rickards AF. Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart. 2004;90:1004–1009
  21. Aronow HD, Novaro GM, Lauer MS, Brennan DM, Lincoff AM, Topol EJ, et al. In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. Arch Intern Med. 2003;163:2576–2582
  22. Bodenheimer T, Fernandez A. High and rising health care costs (Part 4: can costs be controlled while preserving quality?). Ann Intern Med. 2005;143:26–31
  23. Berra K, Miller NH, Fair JM. Cardiovascular disease prevention and disease management: a critical role for nursing. J Cardiopulmonary Rehabil. 2006;26:197–206
  24. Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, et al. An intervention to improve secondary prevention of coronary heart disease. Arch Intern Med. 2007;167:586–590
  25. Hippisley-Cox J, Coupland C. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis. BMJ. 2005;330:1059–1063
  26. McAlister FA. Commentary: relative treatment effects are consistent across the spectrum of underlying risks, usually. Int J Epidemiol. 2002;31:76–77
  27. Unal B, Critchley J, Capewell S. Missing, mediocre, or merely obsolete? (An evaluation of UK data sources for coronary heart disease). J Epidemiol Commun Health. 2003;57:530–535
  28. Briggs A. Economics notes: handling uncertainty in economic evaluation. BMJ. 1999;319:120
  29. Unal B, Critchley J, Fidan D, Capewell S. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981–2000. Am J Pub Health. 2003;95:103–108
  30. Liu JL, Maniadakis N, Gray A, Rayner M. The economic burden of coronary heart disease in the UK. Heart. 2002;88:597–603

 M. O'Flaherty was a Medical Research Council Research Fellow, and E. Ford was employed by the Centers for Disease Control; the funding sources have not been involved in any step of this research.

PII: S0002-9149(09)00600-6

doi: 10.1016/j.amjcard.2009.02.036

American Journal of Cardiology
Volume 103, Issue 12 , Pages 1703-1709 , 15 June 2009

Article Tools

* Image Usage & Resolution